Background: Residual aortic regurgitation was frequent with first generation TAVR devices. Innovations with new generation are aiming to optimize valve performance and improve clinical outcome. Methods: We compared 30 days… Click to show full abstract
Background: Residual aortic regurgitation was frequent with first generation TAVR devices. Innovations with new generation are aiming to optimize valve performance and improve clinical outcome. Methods: We compared 30 days and 12 months outcome of the Boston Scientific Lotus Valve and the Edwards
               
Click one of the above tabs to view related content.